DIAGNOSTIC METHOD CAPABLE OF SIMULTANEOUSLY CONFIRMING DETECTION OF NONTUBERCULOUS MYCOBACTERIA AND MYCOBACTERIUM TUBERCULOSIS AND RESISTANCE TO RIFAMPIN, ISONIAZID, FLUOROQUINOLONES, AND AMINOGLYCOSIDE ANTIBIOTICS OF MYCOBACTERIUM TUBERCULOSIS, AND A KIT THEREOF, BASED ON QUANTA MATRIX ASSAY PLATFORM

摘要

The present invention provides, based on quanta matrix assay platform, a diagnostic method capable of simultaneously confirming detection of nontuberculous mycobacteria and Mycobacterium tuberculosis and resistance to rifampin, isoniazid, ethambutol, fluoroquinolones, and aminoglycoside drugs of Mycobacterium tuberculosis; and a kit thereof. The present invention shortens the time taken for isolating and culturing for a drug resistance test from a sample, makes it possible to efficiently test drug susceptibility of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis for a large number of samples, and can prevent misdiagnosis and prescription errors that may be caused by contamination or mixed infection by nontuberculous mycobacteria.;COPYRIGHT KIPO 2019